The most important financial indicators for the company Zara Sanmed S.r.l. - Unique Identification Number 28019925:
sales in 2023 was
73.255
euro, registering a net profit of
17.304
euro and having an average number of
2
employees.
Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala generala having the NACE code 8621.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 33.3%, from 55.107 euro in the year 2022, to 73.255 euro in 2023.
The Net Profit increased by 3.444 euro, from 13.902 euro in 2022, to 17.304 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Zara Sanmed S.r.l. - CUI 28019925
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
98.205
102.584
67.038
7.150
1.798
2.725
3.830
5.270
5.650
6.528
Current Assets
20.803
26.397
33.254
44.934
59.875
81.976
99.687
32.449
6.820
11.533
Inventories
0
0
0
0
0
0
0
0
1.766
0
Receivables
174
0
252
378
1.310
648
36.527
294
521
4.902
Cash
20.629
26.396
33.003
44.556
58.565
81.328
63.160
32.155
4.532
6.630
Shareholders Funds
26.007
30.876
37.388
23.222
20.242
41.592
56.892
56.403
44.805
58.940
Social Capital
45
45
45
44
43
42
41
40
41
40
Debts
1.323
1.171
1.137
25.542
42.358
42.183
49.944
43.083
64.598
50.798
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"8621 - 8621"
CAEN Financial Year
8621
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
11.533 euro in 2023 which includes Inventories of
0 euro, Receivables of
4.902 euro and cash availability of
6.630 euro.
The company's Equity was valued at
58.940 euro, while total Liabilities amounted to
50.798 euro.
Equity increased by 14.272 euro, from 44.805 euro in 2022, to 58.940 in 2023.
Activate a subscription with unlimited access and get contact details for any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Recurring
- monthly payment
Pay
25,21EUR / month
NELIMITAT
Reports that can be accessed based on the subscription:
✔ Financial Rating
✔ Payment Limits
✔ Outstanding Debts
✔ Probability of Insolvency
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
